Clinical trialObsRecruiting
Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy
Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy; Experience From Two Referral Centers in Central Greece.
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Recruiting
- Study type
- Observational
- Start
- 1 July 2019
- Expected end
- 30 May 2025
- Enrollment
- 170 participants
- Sites
- 1
- Primary outcomes
- impact on length of stay
- Sponsor
- Other
- Results posted
- No
- Last update
- 20 April 2025
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This study assesses whether patients with pancreatic cancer who undergo surgery experience improved outcomes following the implementation of a multidisciplinary care pathway, specifically an enhanced recovery after surgery (ERAS) program. This pathway includes various interventions in the preoperative, intraoperative, and postoperative care of these patients, all aimed at enhancing their health status and postoperative results.
Detailed description public domain (ClinicalTrials.gov)
This prospective observational study is conducted by the same surgical team at two high-volume pancreatic cancer referral centers in Greece. Patients undergoing elective pancreatic surgery are prospectively enrolled and managed according to a standardized ERAS protocol (ERAS group). A control group, which received standard perioperative care before the implementation of ERAS, was retrospectively selected and matched based on demographic and clinical parameters. The primary study endpoint is the length of hospital stay (LOS), while secondary endpoints include 30-day mortality and morbidity.